About this trial
This is an international, multicenter, observational study aimed at investigating acute kidney injury requiring renal replacement therapy (AKI-RRT) in Latin American countries. The main questions this study aims to answer are:
* What is the epidemiology, outcomes, and processes of care for patients with AKI-RRT in Latin America? * How do outcomes differ across different countries in Latin America? * What factors (demographics, clinical, socioeconomic) influence outcomes in patients with AKI-RRT in Latin America?
The main aims of this study are to:
* Establish a comprehensive database containing clinical, laboratory, treatment, process, and outcome data of patients with AKI-RRT in Latin America * Describe current epidemiology of AKI-RRT in Latin America * Compare processes of care and outcomes across different countries in Latin America * Provide data resources to facilitate and promote clinical research in AKI-RRT
Eligibility criteria
Qualifiers
Adult patient (≥18) admitted to the ICU
First ICU admission during current hospitalization
Diagnosis of acute kidney injury stage 3 according to KDIGO guidelines
RRT initiated no earlier than 3 days before or no later than 7 days after ICU admission
Disqualifiers
Transfer from outside hospital with ongoing RRT
RRT exposure of less than 2 days (if CRRT or PD was provided) or less than 2 HD/SLED sessions
Kidney failure (ESRD) patients on maintenance dialysis
Kidney transplant recipients
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
University of Alabama at Birmingham
Lead sponsor
Vantive Health LLC
Collaborator